Human Adrenocortical Carcinoma (NCI-H295R) Cell Line as an In Vitro Cell Culture Model for Assessing the Impact of Iron on Steroidogenesis. 2021

Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture, Nitra, Slovak Republic.

The aim of this in vitro study was to examine the dose-dependent effects of iron as a potential endocrine disruptor in relation to the release of sexual steroid hormones by a human adrenocortical carcinoma (NCI-H295R) cell line. The cells were exposed to different concentrations (3.90, 62.50, 250, 500, 1000 μM) of FeSO4.7H2O and compared with the control group (culture medium without FeSO4.7H2O). Cell viability was measured by the metabolic activity assay. Quantification of sexual steroid production was performed by enzyme-linked immunosorbent assay. Following 48 h culture of the cells in the presence of FeSO4.7H2O, significantly (P < 0.001) increased production of progesterone was observed at the lowest concentration (3.90 μM) of FeSO4.7H2O, whereas the lowest release of progesterone by NCIH295R cells was noted after addition of 1000 μM of FeSO4.7H2O, which did not elicit cytotoxic action (P > 0.05). Testosterone production was substantially increased at the concentrations ≤ 62.50 μM of FeSO4.7H2O. Lower levels of testosterone were recorded in the groups with higher concentrations (≥ 250 μM) of FeSO4.7H2O (P > 0.05). The presented data suggest that iron has no endocrine disruptive effect on the release of sexual steroid hormones, but its toxicity may be reflected at other points of the steroidogenesis pathway.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018268 Adrenocortical Carcinoma A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM. Carcinoma, Adrenal Cortical,Carcinoma, Adrenocortical,Adrenal Cortical Carcinoma,Adrenal Cortical Carcinomas,Adrenocortical Carcinomas,Carcinomas, Adrenal Cortical,Carcinomas, Adrenocortical
D018929 Cell Culture Techniques Methods for maintaining or growing CELLS in vitro. Cell Culture,Cell Culture Technique,Cell Cultures,Culture Technique, Cell,Culture Techniques, Cell

Related Publications

Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
November 2020, Physiological research,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
January 2015, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
January 2007, Endocrinology,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
January 2013, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
February 2017, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
December 2008, The Journal of endocrinology,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
January 2011, Steroids,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
August 1999, Journal of molecular endocrinology,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
April 2007, Environmental toxicology and chemistry,
Z Knazicka, and V Fialkova, and H Duranova, and J Bilcikova, and E Kovacikova, and M Miskeje, and V Valkova, and Z Forgacs, and S Roychoudhury, and P Massanyi, and N Lukac
March 2009, European journal of pharmacology,
Copied contents to your clipboard!